INMODE LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 17.14 USD | +0.71% |
|
-1.55% | -22.93% |
| 12/04 | Barclays Adjusts Price Target on InMode to $33 From $34, Maintains Overweight Rating | MT |
| 09/04 | Sector Update: Health Care Stocks Edge Higher Pre-Bell Tuesday | MT |
| Sales 2024 * | 492M 41.01B | Sales 2025 * | 534M 44.54B | Capitalization | 1.45B 121B |
|---|---|---|---|---|---|
| Net income 2024 * | 199M 16.59B | Net income 2025 * | 216M 18.01B | EV / Sales 2024 * | 0.89 x |
| Net cash position 2024 * | 1.01B 84.33B | Net cash position 2025 * | 1.27B 106B | EV / Sales 2025 * | 0.33 x |
| P/E ratio 2024 * |
7.42
x | P/E ratio 2025 * |
6.88
x | Employees | 581 |
| Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 88.25% |
More Fundamentals
* Assessed data
More news
Latest transcript on InMode Ltd.
More recommendations
More press releases
| 1 day | +0.71% | ||
| 1 week | -1.55% | ||
| Current month | -20.68% | ||
| 1 month | -17.08% | ||
| 3 months | -26.28% | ||
| 6 months | -10.96% | ||
| Current year | -22.93% |
1 week
16.82
17.80
1 month
16.8221.92
Current year
16.8226.80
1 year
16.8248.25
3 years
16.8299.27
5 years
6.5399.27
10 years
6.5399.27
| Managers | Title | Age | Since |
|---|---|---|---|
Michael Kreindel
FOU | Founder | 57 | 02/08/02 |
Moshe Mizrahy
CEO | Chief Executive Officer | 71 | 02/08/02 |
Yair Malca
DFI | Director of Finance/CFO | 46 | 01/17/01 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Bruce Mann
BRD | Director/Board Member | 89 | 07/19/07 |
Moshe Mizrahy
CEO | Chief Executive Officer | 71 | 02/08/02 |
Michael Kreindel
FOU | Founder | 57 | 02/08/02 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.54% | 5 M€ | -1.80% | - | |
| 0.10% | 12 M€ | -.--% | - | |
| 0.10% | 18 M€ | +3.79% | - | |
| 0.05% | 773 M€ | -.--% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26/24/26 | 17.14 | +0.71% | 970,055 |
| 25/24/25 | 17.02 | -1.96% | 1,032,440 |
| 24/24/24 | 17.36 | -0.06% | 924,945 |
| 23/24/23 | 17.37 | +1.34% | 923,636 |
| 22/24/22 | 17.14 | -1.55% | 1,218,459 |
Delayed Quote Nasdaq, April 27, 2024 at 01:30 am IST
More quotes
Inmode Ltd is an Israel-based global provider of energy-based, minimally-invasive surgical medical treatment solutions. Company's products and solutions are primarily designed to address three energy-based treatment categories comprised of: face and body contouring; medical aesthetics; and womenâs health. The Company have developed and commercialized products utilizing medically-accepted RF energy technology, which can penetrate deep into the subdermal fat, allowing adipose tissue remodeling. It's RF energy-based proprietary technologies - Radio Frequency Assisted Lipolysis (RFAL), Deep Subdermal Fractional RF, Simultaneous Fat Destruction and Skin Tightening and Deep Heating Collagen Remodeling for skin and human natural openings- represent a paradigm shift in the minimally-invasive aesthetic solutions market. These technologies are used by physicians to remodel subdermal adipose, or fatty tissue in a variety of procedures.
Calendar
02/05/2024
- Q1 2024 Earnings Release
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
6
Last Close Price
17.14
USD
Average target price
27.6
USD
Spread / Average Target
+61.03%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -22.93% | 1.45B | |
| +8.07% | 219B | |
| +6.59% | 183B | |
| +11.26% | 133B | |
| +26.57% | 108B | |
| +13.35% | 52.02B | |
| -0.62% | 48.2B | |
| -0.93% | 40.37B | |
| +11.54% | 39.35B | |
| +26.76% | 32.03B |
- Stock Market
- Equities
- INMD Stock
